Contrast Medium Use

American Journal of Cardiology

Volumn 98, Issue 6 SUPPL. 1, 2006, Pages 42-58

  Davidson, Charles ^a   Stacul, Fulvio ^b   McCullough, Peter A ^c   Tumlin, James ^d   Adam, Andy ^e   Lameire, Norbert ^f   Becker, Christoph R ^g  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d Southeast Renal Research Institute SERRI   (United States)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CARBON DIOXIDE; DIATRIZOATE; DOPAMINE; GADOLINIUM; IOBITRIDOL; IODINE; IODIXANOL; IOHEXOL; IOMEPROL; IONIC CONTRAST MEDIUM; IOPAMIDOL; IOPROMIDE; IOTALAMIC ACID; IOTROLAN; IOVERSOL; IOXAGLIC ACID; IOXITALAMIC ACID; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; NONIONIC CONTRAST MEDIUM; OMNIGRAF; THEOPHYLLINE;

ABDOMINAL ANGIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG SAFETY; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PHLEBOGRAPHY; META ANALYSIS; NEPHROTOXICITY; NONHUMAN; OSMOLALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIATION DOSE; SYSTEMATIC REVIEW;

CARBON DIOXIDE; CONSENSUS DEVELOPMENT CONFERENCES; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; OSMOLAR CONCENTRATION; RENAL INSUFFICIENCY, ACUTE; RISK FACTORS;

EID: 33747883122     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.023     Document Type: Article

References (109)

1. Alwall N., Erlanson P., and Tornberg A. This clinical course of renal failure occurring after intravenous urography and/or retrograde pyelography; casuistics of 11 cases (including 7 deaths); on indications for and risks involved in the use of contrast media, including some remarks on the risk of aspiration biopsy of the kidney. Acta Med Scand 152 (1955) 163-173
2. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
3. Rudnick M.R., Goldfarb S., Wexler L., Ludbrook P.A., Murphy M.J., Halpern E.F., Hill J.A., Winniford M., Cohen M.B., and VanFossen D.B. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47 (1995) 254-261
4. Moore R.D., Steinberg E.P., Powe N.R., Brinker J.A., Fishman E.K., Graziano S., and Gopalan R. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 182 (1992) 649-655
5. Katholi R.E., Taylor G.J., Woods W.T., Womack K.A., Katholi C.R., McCann W.P., Moses H.W., Dove J.T., Mikell F.L., Woodruff R.C., et al., Prairie Education Research Cooperative. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings. Radiology 186 (1993) 183-187
6. Hayami S., Ishigooka M., Suzuki Y., Hashimoto T., Nakada T., and Mitobe K. Comparison of the nephrotoxicity between ioversol and iohexol. Int Urol Nephrol 28 (1996) 615-619
7. Jakobsen J.A., Berg K.J., Brodahl U., Laake B., and Moxness A. Renal effects of nonionic contrast media after cardioangiography. Acta Radiol 35 (1994) 191-196
8. Campbell D.R., Flemming B.K., Mason W.F., Jackson S.A., Hirsch D.J., and MacDonald K.J. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J 41 (1990) 133-137
9. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
10. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
11. Jakobsen J.A., Berg K.J., Kjaersgaard P., Kolmannskog F., Nordal K.P., Nossen J.O., and Rootwelt K. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention. Nephron 73 (1996) 549-556
12. Carraro M., Malalan F., Antonione R., Stacul F., Cova M., Petz S., Assante M., Grynne B., Haider T., Palma L.D., and Faccini L. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 8 (1998) 144-147
13. Andersen P.E., Bolstad B., Berg K.J., Justesen P., Thayssen P., and Kloster Y.F. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol 48 (1993) 268-272
14. Andrew E., Berg K.J., Nossen J.O., Kvamme A.M., Seim E., Jakobsen J.A., and Grynne B.H. Renal effects of iodixanol in patients: a comparison with other radiographic contrast media. Acad Radiol 3 suppl 2 (1996) S440-S443
15. Donadio C., Lucchesi A., Ardini M., Tramonti G., Chella P., Magagnini E., and Bianchi C. Renal effects of cardiac angiography with different low-osmolar contrast media. Ren Fail 23 (2001) 385-396
16. Donadio C., Lucchesi A., Tramonti G., Calderazzi A., Gibilisco G., Paolicchi A., Giordani R., and Bianchi C. Glomerular and tubular effects of contrast media diatrizoate and iopromide. Ren Fail 18 (1996) 657-666
17. Donadio C., Tramonti G., Giordani R., Lucchetti A., Calderazzi A., Ferrari P., and Bianchi C. Renal effects and nephrotoxicity of contrast media in renal patients. Contrib Nephrol 101 (1993) 241-250
18. Drobnie-Kovac D., Cerne A., Kranjec I., and Globokar Z.M. Effects of nonionic radiographic contrast media on renal function after cardiac catheterisation. Radiol Oncol 30 (1996) 95-99
19. Fischbach R., Landwehr P., Lackner K., Nossen J.O., Heindel W., Berg K.J., Eichhorn G., and Jacobsen T.F. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial. Eur Radiol 6 (1996) 9-13
20. Henzlova M.J., Bittner V., Bourge R.C., Nath H., Kirklin J.K., and Rogers W.J. Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heart. J Heart Lung Transplant 11 (1992) 584-586
21. Jakobsen J.A., Kolbenstvedt A.N., and Berg K.J. Renal effects of iopentol and iohexol after intravenous injection. Acta Radiol 32 (1991) 320-324
22. Klow N.E., Levorstad K., Berg K.J., Brodahl U., Endresen K., Kristoffersen D.T., Laake B., Simonsen S., Tofte A.J., and Lundby B. Iodixanol in cardioangiography in patients with coronary artery disease: tolerability, cardiac and renal effects. Acta Radiol 34 (1993) 72-77
23. Millward S.F., Burbridge B.E., Hartman N.G., Moher D., and Chamberlain M.J. Nephrotoxicity of ioxaglate and ioversol assessed by glomerular filtration rate: a pilot study. Can Assoc Radiol J 47 (1996) 24-29
24. Murakami R., Tajima H., and Kumazaki T. Effect of iomeprol on renal function immediately after abdominal angiography. Acta Radiol 37 (1996) 962-965
25. Murakami R., Tajima H., Kumazaki T., and Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography: clinical comparison with iomeprol and ioxaglate. Acta Radiol 39 (1998) 368-371
26. Nikonoff T., Skau T., Berglund J., Nyberg P., Spangberg-Viklund B., and Larsson R. Effects of femoral arteriography and low osmolar contrast agents on renal function. Acta Radiol 34 (1993) 88-91
27. Pugh N.D., Sissons G.R., Ruttley M.S., Berg K.J., Nossen J.O., and Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 47 (1993) 96-99
28. Singh K., Sundgren R., Bolstad B., Bjoerk L., and Lie M. Iodixanol in abdominal digital subtraction angiography: a randomized, double-blind, parallel trial with iodixanol and iohexol. Acta Radiol 34 (1993) 242-245
29. Tveit K., Bolz K.D., Bolstad B., Haugland T., Berg K.J., Skjaerpe T., and Kloster Y.F. Iodixanol in cardioangiography: a double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 35 (1994) 614-618
30. Tytle T., Prati Jr. R.C., Azodo M.V., and Gutierrez O. A prospective, parallel, double-blind comparison of iodixanol and iohexol in extremity phlebography. Acad Radiol 3 (1996) S519-S523
31. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
32. Clauss W., Dinger J., and Meissner C. Renal tolerance of iotrolan 280-a meta analysis of 14 double-blind studies. Eur Radiol 5 suppl (1995) S79-S84
33. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 68 (2005) 2256-2263
34. Ailawadi G., Stanley J.C., Williams D.M., Dimick J.B., Henke P.K., and Upchurch G.R. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 37 (2003) 346-352
35. Bellin M.F., Deray G., Assogba U., Auberton E., Ghany F., Dion-Voirin E., Jacobs C., and Grellet J. Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure. Magn Reson Imaging 10 (1992) 115-118
36. Hammer F.D., Goffette P.P., Malaise J., and Mathurin P. Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9 (1999) 128-136
37. Hammer F.D., Malaise J., Goffette P.P., and Mathurin P. Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure. Transplant Proc 32 (2000) 432-433
38. Haustein J., Niendorf H.P., Krestin G., Louton T., Schuhmann-Giampieri G., Clauss W., and Junge W. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27 (1992) 153-156
39. Kaufman J.A., Geller S.C., Bazari H., and Waltman A.C. Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency-early experience. Radiology 212 (1999) 280-284
40. Rieger J., Sitter T., Toepfer M., Linsenmaier U., Pfeifer K.J., and Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17 (2002) 824-828
41. 2- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency. AJR Am J Roentgenol 176 (2001) 1305-1311
42. Tombach B., Bremer C., Reimer P., Kisters K., Schaefer R.M., Geens V., and Heindel W. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 218 (2001) 651-657
43. Prince M.R., Arnoldus C., and Frisoli J.K. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6 (1996) 162-166
44. Schenker M.P., Solomon J.A., and Roberts D.A. Gadolinium arteriography complicated by acute pancreatitis and acute renal failure [letter]. J Vasc Interv Radiol 12 (2001) 393
45. Gemery J., Idelson B., Reid S., Yucel E.K., Pagan-Marin H., Ali S., and Casserly L. Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR Am J Roentgenol 171 (1998) 1277-1278
46. Sam A.D., Morasch M.D., Collins J., Song G., Chen R., and Pereles F.S. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38 (2003) 313-318
47. Thomsen H.S. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14 (2004) 1654-1656
48. Erley C.M., Bader B.D., Berger E.D., Tuncel N., Winkler S., Tepe G., Risler T., and Duda S. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 19 (2004) 2526-2531
49. Nyman U., Elmstaahl B., Leander P., Nilsson M., Golman K., and Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?. Radiology 223 (2002) 311-318
50. Thomsen H.S., Almen T., and Morcos S.K. Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12 (2002) 2600-2605
51. Briguori C., Colombo A., Airoldi F., Melzi G., Michev I., Carlino M., Montorfano M., Chieffo A., Bellanca R., and Ricciardelli B. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 67 (2006) 175-180
52. 2 digital subtraction angiography for renal artery angioplasty in high-risk patients. AJR Am J Roentgenol 173 (1999) 1551-1556
53. Schreier D.Z., Weaver F.A., Frankhouse J., Papanicolaou G., Shore E., Yellin A.E., and Harvey F. A prospective study of carbon dioxide-digital subtraction vs standard contrast arteriography in the evaluation of the renal arteries. Arch Surg 131 (1996) 503-507 discussion 507-508
54. 2 versus with iodinated contrast material for inferior vena cava filter placement: a prospective evaluation. Radiology 216 (2000) 752-757
55. 2 angiography. J Endovasc Ther 10 (2003) 312-316
56. Kessel D.O., Robertson I., Patel J.V., Peters K., Taylor E.J., Denton L.J., and Bambhra B. Carbon-dioxide-guided vascular interventions: technique and pitfalls. Cardiovasc Intervent Radiol 25 (2002) 476-483
57. Rolland Y., Duvauferrier R., Lucas A., Gourlay C., Morcet N., Rambeau M., and Chaperon J. Lower limb angiography: a prospective study comparing carbon dioxide with iodinated contrast material in 30 patients. AJR Am J Roentgenol 171 (1998) 333-337
58. Beese R.C., Bees N.R., and Belli A.M. Renal angiography using carbon dioxide. Br J Radiol 73 (2000) 3-6
59. Fleischmann D. Use of high concentration contrast media: principles and rationale-vascular district. Eur J Radiol 45 suppl 1 (2003) S88-S93
60. Cademartiri F., Luccichenti G., Marano R., Nieman K., Mollet N., de Feyter P.J., Krestin G.P., Pavone P., and Bonomo L. Spiral CT-angiography with one, four, and sixteen slice scanners: technical note. Radiol Med (Torino) 106 (2003) 269-283
61. AbuRahma A.F., Robinson P.A., Boland J.P., Umstot R.K., Clubb E.A., Grandia R.A., Kennard W., and Bastug D.F. Complications of arteriography in a recent series of 707 cases: factors affecting outcome. Ann Vasc Surg 7 (1993) 122-129
62. Gomes A.S., Baker J.D., Martin-Paredero V., Dixon S.M., Takiff H., Machleder H.I., and Moore W.S. Acute renal dysfunction after major arteriography. AJR Am J Roentgenol 145 (1985) 1249-1253
63. Gussenhoven M.J., Ravensbergen J., van Bockel J.H., Feuth J.D., and Aarts J.C. Renal dysfunction after angiography: a risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg (Torino) 32 (1991) 81-86
64. Lang E.K., Foreman J., Schlegel J.U., Leslie C., List A., and McCormick P. The incidence of contrast medium induced acute tubular necrosis following arteriography. Radiology 138 (1981) 203-206
65. Martin-Paredero V., Dixon S.M., Baker J.D., Takiff H., Gomes A.S., Busuttil R.W., and Moore W.S. Risk of renal failure after major angiography. Arch Surg 118 (1983) 1417-1420
66. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
67. Mehta M., Veith F.J., Lipsitz E.C., Ohki T., Russwurm G., Cayne N.S., Suggs W.D., and Feustel P.J. Is elevated creatinine level a contraindication to endovascular aneurysm repair?. J Vasc Surg 39 (2004) 118-123
68. Manske C.L., Sprafka J.M., Strony J.T., and Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (1990) 615-620
69. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., Singh M., Bell M.R., Barsness G.W., Mathew V., Garratt K.N., and Holmes Jr. D.R. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
70. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., Pichard A.D., Kent K.M., Suddath W., and Waksman R. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 59 (2003) 338-343
71. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., Lansky A.J., Moussa I., Stone G.W., Moses J.W., Leon M.B., and Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
72. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G.S., Lansky A.J., Moses J.W., Stone G.W., Leon M.B., and Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
73. Nikolsky E., Mehran R., Lasic Z., Mintz G.S., Lansky A.J., Na Y., Pocock S., Negoita M., Moussa I., Stone G.W., et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 6 (2005) 706-713
74. Nikolsky E., Mehran R., Turcot D.B., Aymong E.D., Mintz G.S., Lasic Z., Lansky A.J., Tsounias E., Moses J.W., Stone G.W., Leon M.B., Dangas G.D., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300-305
75. Bartholomew B.A., Harjai K.J., Dukkipati S., Boura J.A., Yerkey M.W., Glazier S., Grines C.L., and O'Neill W.W. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
76. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., Grazi M., Veglia F., and Bartorelli A.L. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
77. Taliercio C.P., Vlietstra R.E., Fisher L.D., and Burnett J.C. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104 (1986) 501-504
78. Freeman R.V., O'Donnell M., Share D., Meengs W.L., Kline-Rogers E., Clark V.L., DeFranco A.C., Eagle K.A., McGinnity J.G., Patel K., et al., Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90 (2002) 1068-1073
79. Sabeti S., Schillinger M., Mlekusch W., Ahmadi R., and Minar E. Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg 24 (2002) 156-160
80. Albert S.G., Shapiro M.J., Brown W.W., Goodgold H., Zuckerman D., Durham R., Kern M., Fletcher J., Wolverson M., Plummer E.S., et al. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 29 (1994) 618-623
81. Taliercio C.P., McCallister S.H., Holmes D.R., Ilstrup D.M., and Vlietstra R.E. Nephrotoxicity of nonionic contrast media after cardiac angiography. Am J Cardiol 64 (1989) 815-816
82. Miller D.L., Chang R., Wells W.T., Dowjat B.A., Malinosky R.M., and Doppman J.L. Intravascular contrast media: effect of dose on renal function. Radiology 167 (1988) 607-611
83. Cruz C., Hricak H., Samhouri F., Smith R.F., Eyler W.R., and Levin N.W. Contrast media for angiography: effect on renal function. Radiology 158 (1986) 109-112
84. Eisenberg R.L., Bank W.O., and Hedgcock M.W. Renal failure after major angiography. Am J Med 68 (1980) 43-46
85. Hayman L.A., Evans R.A., Fahr L.M., and Hinck V.C. Renal consequences of rapid high dose contrast CT. AJR Am J Roentgenol 134 (1980) 553-555
86. Ogle G.D., Swinburn M.J., and McCredie R.M. Ioxaglate in paediatric angiocardiography. J Paediatr Child Health 27 (1991) 282-285
87. Older R.A., Miller J.P., Jackson D.C., Johnsrude I.S., and Thompson W.M. Angiographically induced renal failure and its radiographic detection. AJR Am J Roentgenol 126 (1976) 1039-1045
88. Parfrey P.S., Griffiths S.M., Barrett B.J., Paul M.D., Genge M., Withers J., Farid N., and McManamon P.J. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 320 (1989) 143-149
89. Swartz R.D., Rubin J.E., Leeming B.W., and Silva P. Renal failure following major angiography. Am J Med 65 (1978) 31-37
90. Zuckerman D.A., Sterling K.M., and Oser R.F. Safety of pulmonary angiography in the 1990s. J Vasc Interv Radiol 7 (1996) 199-205
91. Cigarroa R.G., Lange R.A., Williams R.H., and Hillis L.D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86 (1989) 649-652
92. Vlietstra R.E., Nunn C.M., Narvarte J., and Browne K.F. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 132 (1996) 1049-1050
93. Altmann D.B., Zwas D., Spatz A., Bergman G., Spokojny A., Riva S., and Sanborn T.A. Use of the contrast volume to estimated creatinine clearance ratio to predict renal failure after angiography. J Intervent Cardiol 10 (1997) 113-119
94. Baumgart D., Haude M., George G., Ge J., Rosenbaum S., Caspari G., Liu F., and Erbel R. High-volume nonionic dimeric contrast medium: first experiences during complex coronary interventions. Cathet Cardiovasc Diagn 40 (1997) 241-246
95. Alamartine E., Phayphet M., Thibaudin D., Barral F.G., and Veyret C. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 14 (2003) 426-431
96. Steinberg E.P., Moore R.D., Brinker J.A., Fishman E.K., Powe N.R., Graziano S.L., and Gopalan R. Nephrotoxicity of low osmolality contrast media versus high osmolality media. Invest Radiol 26 suppl 1 (1991) S86 discussion S88-91
97. Khoury G.A., Hopper J.C., Varghese Z., Farrington K., Dick R., Irving J.D., Sweny P., Fernando O.N., and Moorhead J.F. Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br J Radiol 56 (1983) 631-635
98. Lufft V., Hoogestraat-Lufft L., Fels L.M., Egbeyong-Baiyee D., Tusch G., Galanski M., and Olbricht C.J. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis. A prospective randomized trial. Am J Kidney Dis 40 (2002) 236-242
99. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
100. Gates G.F., and Green G.S. Transient reduction in renal function following arteriography: a radionuclide study. J Urol 129 (1983) 1107-1110
101. Chanard J., Jolly D., Doco J.B., Bouquigny F., Wynckel A., Lacour P., Menanteau B., and Elaerts J. Nephrotoxicity of conventional and low osmolality radiocontrast media. J Nephrol 4 (1991) 203-209
102. Krumlovsky F., Simon N., Santhanam S., del Greco F., Roxe D., and Pomeranc M. Acute renal failure (ARF) secondary to administration of radiographic contrast material (RCM). [abstract]. Kidney Int 10 (1976) 501
103. Krumlovsky F.A., Simon N., Santhanam S., del Greco F., Roxe D., and Pomaranc M.M. Acute renal failure: association with administration of radiographic contrast material. JAMA 239 (1978) 125-127
104. Cochran S.T., Wong W.S., and Roe D.J. Predicting angiography-induced acute renal function impairment: clinical risk model. AJR Am J Roentgenol 141 (1983) 1027-1033
105. Surowiec S.M., Davies M.G., Fegley A.J., Tanski W.J., Pamoukian V.N., Sternbach Y., Waldman D.L., and Green R.M. Relationship of proximal fixation to postoperative renal dysfunction in patients with normal serum creatinine concentration. J Vasc Surg 39 (2004) 804-810
106. Lufft V., Hoogestraat-Lufft L., Fels L.M., Egbeyong-Baiyee D., Olbricht C.J., and Galanski M. Angiography for renal artery stenosis: no additional impairment of renal function by angioplasty. Eur Radiol 12 (2002) 804-809
107. Guitterez N.V., Diaz A., Timmis G.C., O'Neill W.W., Stevens M.A., Sandberg K.R., and McCullough P.A. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15 (2002) 349-354
108. Sutton T.A., Fisher C.J., and Molitoris B.A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62 (2002) 1539-1549
109. Muntner P., Coresh J., Klag M.J., Whelton P.K., and Perneger T.V. Exposure to radiologic contrast media and an increased risk of treated end-stage renal disease. Am J Med Sci 326 (2003) 353-359